Intermediates
| Product Name | CAS No | Final API |
| N-methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7-[(4-methylphenyl)sulfonyl]- 7H-Pyrrolo[2,3-d]pyrimidin-4-amine | 923036-30-0 | Tofacitinib |
| N-methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]- 7H-Pyrrolo[2,3-d]pyrimidin-4-amine | 477600-73-0 | |
| 2-[4-(bromomethyl)phenyl]benzonitrile | 114772-54-2 | Azilsartan |
| Methyl 2-ethoxybenzimidazole-7-carboxylate | 150058-27-8 | |
| Methyl 1-[(2'-cyanobiphenyl-4-yl)methyl]- 2-ethoxy-1H-benzimidazole-7-carboxylate |
139481-44-0 | |
| Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimidazole]-7-Carboxylate | 139481-41-7 | |
| 1,2,3,4-tetrahydro-naphthoic acid | 1914-65-4 | Palonosetron |
| 2-(4-chlorophenyl)ethanol | 1875-88-3 | Lorcaserin HCl |
| 2-(4-Chlorophenyl)ethylamine | 156-41-2 | |
| ((R )-1-aminopropan-2-ol) | 2799-17-9 | |
| 1-[[2-(4-Chlorophenyl)ehyl]amino]-2-chloropropane hydrochloride | 953789-37-2 | |
| 4-hydroxybenzenepropanoic acid[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl] methylester | 144256-11-1 | Landiolol HCL |
| (2S)-( )-glycidyl-3-nitrobenzensulfonate | 115314-14-2 | |
| (1S,5R,6S)-Ethyl 5-(pentan-3-yl-oxy)-7-oxa- bicyclo[4.1.0]hept-3-ene-3-carboxylate(SHEP) |
204254-96-6 | Oseltamivir |
| IMEE : 4-(1-Hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylic acid ethyl ester |
144689-93-0 | |
| medoxomil-Cl :4-Chloromethyl-5-methyl -1,3-dioxol-2-one |
80841-78-7 |
|
| Regorafenib hydrate | 755037-03-7 | Regorafenib |
| 2-(N-Methylcaramoyl)-4-chloropyridine | 220000-87-3 | |
| 2-Fluoro-4-hydroxyaniline | 399-95-1 | |
| 1-Chloro-4-isocyanato-2-(trifluoromethyl)benzene | 327-78-6 | |
| 2-hydroxy-3-methoxy-3,3-diphenylpropanoic acid methyl ester | 178306-47-3 | Ambrisentan |
| 4,6-Dimethyl-2-(methylsulfonyl)pyrimidine | 35144-22-0 | |
| (R)-(-)-3-(carbamoymethyl)-5-methyl hexanoic acid | Pregabarin | |
| 4-tert-butyl benzenesulfonamide (4-TBBSA) | 6292-59-7 | Bosentan |